NCT01702311View on ClinicalTrials.gov

Point-of-Care Glucose Testing and Insulin Supplementation

NACompletedINTERVENTIONAL
Enrollment

235

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Diabetes
Interventions
DRUG

Bedtime insulin Aspart (Novolog)

Bedtime insulin aspart supplementation based on blood glucose value in the bedtime supplementation arm.

Trial Locations (2)

30303

Grady Memorial Hospital, Atlanta

30322

Emory University Hospital, Atlanta

All Listed Sponsors
lead

Emory University

OTHER

NCT01702311 - Point-of-Care Glucose Testing and Insulin Supplementation | Biotech Hunter | Biotech Hunter